News | Cardiovascular diseases

Feature

Spilling the beans on the health impacts of coffee

On average, 98 million cups of coffee are consumed each day in the UK. Is this popular drink harmful or do its benefits outweigh its risks?…

Published: 14 April 2022

News

More than 31,000 interventions carried out by community pharmacy under hypertension service, data show

The 'NHS community pharmacy blood pressure check service', which launched in October 2021, aims to identify people aged 40 years and older with high blood pressure.…

Published: 23 March 2022

News

Pharmacist intervention significantly reduces cardiovascular risk factors, finds review

Researchers looked at data from 24 studies with 85 meta-analyses that assessed pharmacist interventions, such as medication reviews, patient education and drug therapy management.…

Published: 21 February 2022

News

NICE recommends wider offering of dual metformin and SGLT2 inhibitor treatment in type 2 diabetes patients

The new guidance recommends offering the first-line treatment to patients with type 2 diabetes mellitus who have chronic heart failure or established cardiovascular disease.…

Published: 17 February 2022

News

Nearly 4,000 pharmacies offering blood pressure monitoring service, says NHS England

Since the introduction of the hypertension case-finding service in October 2021, 3,938 pharmacies have signed up to provide blood pressure checks.…

Published: 8 February 2022

News

Pilot launched to investigate use of genetic testing to predict heart disease risk

The biotech company Genomics has suggested that rolling out its genetic testing across England among individuals aged 45 to 64 years could cut the number of cardiovascular events by 11,000 over 10 years.…

Published: 18 January 2022

Feature

How COVID-19 turned anticoagulation on its head

In an effort to reduce face-to-face consultations during the COVID-19 pandemic, anticoagulation services were encouraged to switch as many patients from warfarin to a direct oral anticoagulant as possible. Here, we investigate how this has been going.…

Published: 9 December 2021

Letter

We need genuine evidence on inclisiran, not hyperbole

The views expressed in this letter are those of the author’s. If you would like to submit a letter to The Pharmaceutical Journal, please click here. In July 2017, The Pharmaceutical Journal published an opinion article, 'The cholesterol and calorie hypotheses are both dead — it is …

Published: 15 October 2021

News

Injectable treatment recommended by NICE for patients with high cholesterol

The cholesterol-lowering treatment inclisiran could be a "game-changer" in preventing heart attacks and strokes, says the National Institute for Health and Care Excellence.…

Published: 1 September 2021

News

Pharmacists can provide drug treatment for hypertension, WHO guideline says

The World Health Organization has published a new hypertension guideline that states “non-physician professionals” can provide pharmacological antihypertensive treatment, as long as certain conditions are met.…

Published: 31 August 2021